Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023
Compare Profit and Loss Results of Fredun Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
407.00
-59.00
-14.50%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
407.00
-59.00
-14.50%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
-2.00
-20.00
-1,000.00%
Raw Materials Consumed
282.00
197.00
85.00
43.15%
Power & Fuel Cost
4.00
11.00
-7.00
-63.64%
Employee Cost
12.00
57.00
-45.00
-78.95%
Operating Expenses
10.00
24.00
-14.00
-58.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
24.00
-19.00
-79.17%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
333.00
-23.00
-6.91%
Operating Profit (PBDIT) excl Other Income
37.00
74.00
-37.00
-50.00%
Other Income
0.00
20.00
-20.00
-100.00%
Operating Profit (PBDIT)
38.00
94.00
-56.00
-59.57%
Interest
13.00
10.00
3.00
30.00%
Profit before Depriciation and Tax
25.00
83.00
-58.00
-69.88%
Depreciation
3.00
12.00
-9.00
-75.00%
Profit Before Taxation & Exceptional Items
21.00
70.00
-49.00
-70.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
70.00
-49.00
-70.00%
Provision for Tax
5.00
23.00
-18.00
-78.26%
Profit After Tax
15.00
47.00
-32.00
-68.09%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
145.00
-117.00
-80.69%
Profit Available for appropriations
44.00
193.00
-149.00
-77.20%
Appropriations
44.00
193.00
-149.00
-77.20%
Equity Dividend (%)
7%
10%
-3.00
Earnings Per Share
33.66
1.41
32.25
2,287.23%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023






